688198.SS · 佰仁医疗
China A-shares · RS rating 17 · As of 2026-10-14
| Price | 69.80 CNY |
|---|---|
| 1-day change | -2.6% |
| RS rating (overall / 1M / 3M / 12M) | 17 / 70 / 23 / 18 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 21 / 14 / 17 |
| Industry group (rank) | Medical-Products (64) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -23.2% |
| Distance from 52-week high | +47.1% |
| Market cap (USD) | $1.4B |